A special form of chromoanasynthesis occurs in triple-negative breast cancer and in ovarian, endometrial, and liver cancers that originate from individuals with a genetic defect affecting the homologous recombination protein BRCA1, or in clones that have lost BRCA1 and TP53 by mutation. Here, TP53 is linked to triple-negative breast carcinoma.